Home Newsfeeds BTIG Upgrades Agilysys to Buy

BTIG Upgrades Agilysys to Buy

BTIG analyst Matthew Vanvliet upgrades Agilysys (NASDAQ:AGYS) from Neutral to Buy.

byBenzinga Newsdesk

December 16, 2022

1 minute read

BTIG analyst Matthew Vanvliet upgrades Agilysys (NASDAQ:AGYS) from Neutral to Buy.

‘See The Problem?’: Short Seller Jim Chanos Rips Into Trump’s DWAC Stock Valuation Amid Share Spike

By Chris Katje

November 7, 4:44 PM

A leading short seller is warning investors to remain cautious on one of Monday's the top stock gainers. Here’s a look at one of the biggest stocks related to Donald Trump and why it’s moving and what could be next.

DWAC

Tabula Rasa HealthCare Q4 Adj. EPS $(0.05) Beats $(0.06) Estimate

By Michael Horton

March 6, 6:51 PM

Tabula Rasa HealthCare (NASDAQ:TRHC) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 44.44 percent increase over losses of $(0.09) per share

TRHC

Analyst Ratings

Needham Maintains Buy Rating for I-MAB: Here’s What You Need To Know

By Benzinga Insights

August 17, 12:29 PM

Needham has decided to maintain its Buy rating of I-MAB (NASDAQ:IMAB) and lower its price target from $72.00 to $41.00. Shares of I-MAB are trading down 15.43% over the last 24 hours, at $6.74 per share.

IMAB

News
Tech

Now Listen To Webpages Using Google Chrome Browser In Two Simple Steps: Here’s How

By Ananya Gairola

June 17, 4:46 AM

Google adds feature to Chrome browser, Listen to this page, allowing playback controls for multiple languages. Direct competitor to Apple's Siri feature in Safari app.

AAPL

BTIG Upgrades Agilysys to Buy

Related Posts

‘See The Problem?’: Short Seller Jim Chanos Rips Into Trump’s DWAC Stock Valuation Amid Share Spike

Tabula Rasa HealthCare Q4 Adj. EPS $(0.05) Beats $(0.06) Estimate

Needham Maintains Buy Rating for I-MAB: Here’s What You Need To Know

Now Listen To Webpages Using Google Chrome Browser In Two Simple Steps: Here’s How